Long-term follow-up of Graves ophthalmopathy in an incidence cohort
- PMID: 8643255
- DOI: 10.1016/s0161-6420(96)30579-4
Long-term follow-up of Graves ophthalmopathy in an incidence cohort
Abstract
Purpose: To provide long-term follow-up data on patients with Graves ophthalmopathy in an incidence cohort of 120 patients.
Methods: Data were obtained from a comprehensive review of each patient's community medical record, a follow-up survey, or both.
Results: The median interval between the initial ophthalmic examination and most recent follow-up was 9.8 years (range, 64 days to 17.4 years). Follow-up of more than 5 years was available for 96 patients (80.0 percent), whereas follow-up exceeding 10 years was achieved for 59 patients (49.2 percent). Persistent visual loss from optic neuropathy occurred in two eyes, with final visual acuities of 20/30 and 20/60, respectively. None of the patients reported deterioration of vision attributable to Graves ophthalmopathy in the interval since their last ophthalmic examination at the authors' institution. Two patients (2.2 percent) had constant diplopia, but it was correctable with spectacles (prisms) in each case. Nearly one third of respondents had had ocular discomfort during the preceding 4 weeks; the most frequent cause in 72 percent of patients was dry eyes. Among the respondents to the survey, 60.5 percent believed that the appearance of their eyes had not returned to what it had been before the development of thyroid disease, 51.6 percent thought that their eyes appeared abnormal, and 37.9 percent were dissatisfied with the appearance of their eyes.
Conclusions: Although with treatment few patients have long-term functional impairment from Graves ophthalmopathy, more than one third of patients are dissatisfied with their ultimate appearance. The psychologic, aesthetic, economic, and social sequelae of the disorder require further definition by formal outcomes studies.
Similar articles
-
Chronology of Graves' ophthalmopathy in an incidence cohort.Am J Ophthalmol. 1996 Apr;121(4):426-34. doi: 10.1016/s0002-9394(14)70439-8. Am J Ophthalmol. 1996. PMID: 8604736
-
Clinical features of Graves' ophthalmopathy in an incidence cohort.Am J Ophthalmol. 1996 Mar;121(3):284-90. doi: 10.1016/s0002-9394(14)70276-4. Am J Ophthalmol. 1996. PMID: 8597271
-
The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.Trans Am Ophthalmol Soc. 1994;92:477-588. Trans Am Ophthalmol Soc. 1994. PMID: 7886878 Free PMC article.
-
Graves' ophthalmopathy--a clinical review.Aust N Z J Ophthalmol. 1990 Aug;18(3):239-42. Aust N Z J Ophthalmol. 1990. PMID: 2261168 Review.
-
[Dysthyroid optic neuropathy. Apropos of 2 cases].J Fr Ophtalmol. 1996;19(8-9):543-50. J Fr Ophtalmol. 1996. PMID: 8944137 Review. French.
Cited by
-
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity.J Clin Endocrinol Metab. 2023 Dec 21;109(1):25-35. doi: 10.1210/clinem/dgad637. J Clin Endocrinol Metab. 2023. PMID: 37925673 Free PMC article. Clinical Trial.
-
Graves' ophthalmopathy: state of the art and perspectives.J Endocrinol Invest. 2004 Mar;27(3):295-301. doi: 10.1007/BF03345280. J Endocrinol Invest. 2004. PMID: 15165007 Review.
-
Change in quality of life after medical and surgical treatment of graves' ophthalmopathy.Middle East Afr J Ophthalmol. 2011 Jan;18(1):42-7. doi: 10.4103/0974-9233.75884. Middle East Afr J Ophthalmol. 2011. PMID: 21572733 Free PMC article.
-
Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?J Endocrinol Invest. 2003 Jan;26(1):5-16. doi: 10.1007/BF03345116. J Endocrinol Invest. 2003. PMID: 12602528
-
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.Orphanet J Rare Dis. 2017 Apr 20;12(1):72. doi: 10.1186/s13023-017-0625-1. Orphanet J Rare Dis. 2017. PMID: 28427469 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical